In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
The new test that launched in February 2020 by Mayo Clinic Laboratories:
- Intact Fibroblast Growth Factor 23 , Serum (Mayo ID: IFG23)
In addition to this new test, the department also announced several test changes. Click the links below to view test changes announced by Mayo Clinic Laboratories: